New England Journal of Medicine
The New England Journal of Medicine (NEJM) is the world’s leading medical journal and website. Published continuously for over 200 years, NEJM delivers high-quality, peer-reviewed research and interactive clinical content to physicians, educators, and the global medical community...
Unclaimed profile — some fields may be incomplete.
Metrics
Campos Scimago / CoP — sin series inventadas
SJR Impact
19,076
H-index
1231
Docs (year)
1282
Docs 3y
4249
Total refs
13922
Cites 3y
81934
Citable 3y
1749
Cites/Doc 2y
18.37
Ref/Doc
10.86
Immediate OA
0 €
Embargoed OA
NPD
Non OA / Submission
- €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Clinical Characteristics of Coronavirus Disease 2019 in China
A Novel Coronavirus from Patients with Pneumonia in China, 2019
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
18063 Citations View moreRadiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
13243 Citations View moreImproved Survival with Ipilimumab in Patients with Metastatic Melanoma
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
Sorafenib in Advanced Hepatocellular Carcinoma
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome
9032 Citations View moreActivating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Intensive Insulin Therapy in Critically Ill Patients
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock